Related Experiment Video

Updated: Aug 21, 2026

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Cholesterol metabolism and its implications for therapeutic interventions in patients with hypercholesterolaemia

H Gylling1

  • 1Department of Clinical Nutrition, University of Kuopio, and Kuopio University Hospital, Kuopio, Finland. helena.gylling@uku.fi

International Journal of Clinical Practice
|November 9, 2004
PubMed

Insights

High cholesterol contributes to heart disease. Understanding the balance between cholesterol absorption and synthesis is key to developing effective treatments that lower cholesterol levels.

Area of Science:

  • Biochemistry
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Cardiovascular diseases (CVDs) are a leading cause of mortality in middle-aged and older adults.
  • Coronary heart disease (CHD), a common CVD, is linked to high serum cholesterol and atherosclerosis.
  • Cholesterol homeostasis depends on a balance between intake, absorption/excretion, and synthesis.

Purpose of the Study:

  • To explore the intricate relationship between cholesterol synthesis and absorption.
  • To highlight the limitations of targeting single pathways in cholesterol management.
  • To propose integrated treatment strategies for lowering cholesterol.

Main Methods:

  • Review of experimental studies and clinical trials on cholesterol metabolism.
  • Analysis of the interplay between cholesterol synthesis inhibition and absorption.
  • Examination of the impact of cholesterol absorption inhibition on synthesis.

Main Results:

  • Inhibition of cholesterol synthesis increases cholesterol absorption.
  • Inhibition of cholesterol absorption enhances cholesterol synthesis.
  • These processes are tightly linked, influencing cholesterol homeostasis.

Conclusions:

  • Targeting only cholesterol synthesis or absorption has limitations in managing cholesterol levels.
  • Understanding the interrelationship is crucial for developing effective, integrated treatment regimens.
  • Combined therapies targeting multiple mechanisms may offer superior cholesterol-lowering effects.

More Related Videos

Cholesterol Efflux Assay07:54

Cholesterol Efflux Assay

Published on: March 6, 2012

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...